Gold­man Sachs clos­es $650M life sci­ences fund to bankroll in­dus­try’s ‘gold­en era’

The Big Banks are cap­i­tal­iz­ing on the drug de­vel­op­ment and di­ag­nos­tics world, with Gold­man Sachs As­set Man­age­ment clos­ing out its first life sci­ences fund at …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER